Hedyeh Ebrahimi, Postdoctoral fellow at City of Hope, shared a post by Neeraj Agarwal, Professor of Medicine and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), on X, adding:
“Thank you Neeraj Agarwal for highlighting our study. So grateful to our amazing team City of Hope and Alex Chehrazi-Raffle.”
Quoting Neeraj Agarwal‘s post:
“Congrats Hedyeh Ebrahimi for abstract 5087 ASCO
Among 308 patients with NEPC (neuroendocrine prostate cancer), only 1/3rd met the genomic criteria for AVPC-MS (≥2 alt in TP53, RB1, PTEN)”
Abstract Title: Genomic landscape and clinical characteristics of patients (pts) with neuroendocrine prostate cancer (NEPC) with or without aggressive variant prostate cancer characterized by molecular signature (AVPC-MS).
Authors: Hedyeh Ebrahimi, Regina Barragan-Carrillo, Miguel Zugman, Salvador Jaime-Casas, Koral Shah, Daniela Castro, Benjamin Mercier, Zeynep Zengin, Luis Meza, Xiaochen Li, Joann Hsu, Peter Zang, Nazli Dizman, Charles Nguyen, Abhishek Tripathi, Tanya Dorff, Sumanta Pal, Alex Chehrazi-Raffle
Read Full Abstract on ASCO.
More posts featuring ASCO 2025.
